Anthony Marvin

Prolong Pharmaceuticals, LLC, based in South Plainfield, NJ, is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for complex diseases, including ischemia, hypoxia within stroke, sickle cell disease, and cystic fibrosis. With a leadership team experienced in biotechnology and a pioneering approach to PEGylation, Prolong aims to meet critical unmet medical needs through its cutting-edge biopharma solutions. The company's flagship product, PP-007 Sanguinate, employs a novel PEGylated technology to restore homeostasis by delivering oxygen to hypoxic tissues and facilitating improved perfusion while reducing inflammation. Prolong Pharmaceuticals is committed to advancing healthcare through groundbreaking therapies targeting severe and life-threatening conditions, with a strong focus on addressing the global health issue of stroke. Generated from the website

Located in the vibrant city of Piscataway, NJ, Appco Pharmaceuticals stands as a leading player in the pharmaceutical industry. This innovative company prides itself on pushing boundaries and striving for excellence in the development of cutting-edge medical solutions. At Appco Pharmaceuticals, a dedicated team of professionals works tirelessly to research, create, and distribute pharmaceutical products that have a positive impact on global health. With a focus on technological advancement and a commitment to quality, this company continues to make significant contributions to the field of healthcare. Generated using this place's available information

Rising Pharmaceuticals Inc is a leading provider of generic prescription pharmaceutical products, offering a wide range of therapeutic areas and dosage forms. With state-of-the-art manufacturing facilities, they specialize in producing APIs, intermediates, and challenging dosage forms, including injectables and ophthalmics. Committed to improving lives, Rising Pharmaceuticals aims to make a positive impact on patients, healthcare workers, and the entire supply chain. As an innovative and entrepreneurial company, Rising Pharmaceuticals has recently expanded its sterile dosage capabilities with the opening of a new facility, strengthening the U.S. supply chain. They have also launched important antidote treatments, such as the Edetate Calcium Disodium Injection for addressing lead poisoning. Additionally, Rising Pharmaceuticals actively supports clinical trials, like the Phase 2 trial of Chloroquine Phosphate, to combat COVID-19 and protect healthcare workers at risk. With a focus on integrity, responsibility, service, collaboration, and teamwork, Rising Pharmaceuticals strives to provide high-quality pharmaceutical products that enhance the well-being of individuals and communities.Generated from the website